‘Long flu’ has emerged as consequence similar to long COVID

Since the COVID-19 pandemic began, extensive research has emerged detailing the virus’s ability to attack multiple organ systems, potentially resulting in a set of enduring and often disabling health problems known as long COVID. Now, new research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System indicates that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways.

The new study comparing the viruses that cause COVID-19 and the flu also revealed that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and health problems in many organ systems. Further, the time of highest risk was 30 days or later after initial infection.

“The study illustrates the high toll of death and loss of health following hospitalization with either COVID-19 or seasonal influenza,” said senior author Ziyad Al-Aly, MD, a clinical epidemiologist at Washington University. “It’s critical to note that the health risks were higher after the first 30 days of infection. Many people think they’re over COVID-19 or the flu after being discharged from the hospital. That may be true for some people. But our research shows that both viruses can cause long-haul illness.”

The findings are published Dec. 14 in The Lancet Infectious Diseases.

The statistical analysis spanned up to 18 months post-infection and included a comparative evaluation of risks of death, hospital admissions and 94 adverse health outcomes involving the body’s major organ systems.

“A review of past studies on COVID-19 versus the flu focused on a short-term and narrow set of health outcomes,” said Al-Aly, who treats patients within the VA St. Louis Health Care System and is an assistant professor of medicine at Washington University. “Our novel approach compared the long-term health effects of a vast array of conditions. Five years ago, it wouldn’t have occurred to me to examine the possibility of a ‘long flu.’ A major lesson we learned from SARS-CoV-2 is that an infection that initially was thought to only cause brief illness also can lead to chronic disease. This revelation motivated us to look at long-term outcomes of COVID-19 versus flu.

“We wanted to know whether and to what degree people with flu also experience long-term health effects,” Al-Aly said. “The big answer is that both COVID-19 and the flu led to long-term health problems, and the big aha moment was the realization that the magnitude of long-term health loss eclipsed the problems that these patients endured in the early phase of the infection. Long COVID is much more of a health problem than COVID, and long flu is much more of a health problem than the flu.”

However, the overall risk and occurrence of death, hospital admissions, and loss of health in many organ systems are substantially higher among COVID-19 patients than among those who have had seasonal influenza, Al-Aly said. “The one notable exception is that the flu poses higher risks to the pulmonary system than COVID-19,” he said. “This tells us the flu is truly more of a respiratory virus, like we’ve all thought for the past 100 years. By comparison, COVID-19 is more aggressive and indiscriminate in that it can attack the pulmonary system, but it can also strike any organ system and is more likely to cause fatal or severe conditions involving the heart, brain, kidneys and other organs.”

The researchers analyzed de-identified medical records in a database maintained by the U.S. Department of Veterans Affairs, the nation’s largest integrated health-care delivery system. They evaluated information involving 81,280 patients hospitalized for COVID-19 at some point from March 1, 2020, through June 30, 2022, as well as 10,985 patients hospitalized for seasonal influenza at some point from Oct. 1, 2015, through Feb. 28, 2019.

Patients represented multiple ages, races and sexes.

Regarding both viruses, patient vaccination status did not affect results. Those in the COVID-19 cohort were hospitalized during the pre-delta, delta and omicron eras.

During the overall 18-month study period, patients who had COVID-19 faced a 50% higher risk of death than those with seasonal influenza. This corresponded to about eight more deaths per 100 persons in the COVID-19 group than among those with the flu.

Although COVID-19 showed a greater risk of health loss than seasonal influenza, infection with either virus carried significant risk of disability and disease. The researchers found COVID-19 exhibited increased risk of 68% of health conditions examined across all organ systems (64 of the 94 adverse health outcomes studied), while the flu was associated with elevated risk of 6% of health conditions (six of the 94) — mostly in the respiratory system.

Also, over 18 months, COVID-19 patients experienced an increased risk of hospital readmission as well as admission to an intensive care unit (ICU). For every 100 persons in each group, there were 20 more hospital admissions and nine more ICU admissions in COVID-19 than flu.

“Our findings highlight the continued need to reduce the risk of hospitalization for these two viruses as a way to alleviate the overall burden of health loss in populations,” Al-Aly said. “For both COVID-19 and seasonal influenza, vaccinations can help prevent severe disease and reduce the risk of hospitalizations and death. Optimizing vaccination uptake must remain a priority for governments and health systems everywhere. This is especially important for vulnerable populations such as the elderly and people who are immunocompromised.”

In both COVID-19 and the flu, more than half of death and disability occurred in the months after infection as opposed to the first 30 days, the latter of which is known as the acute phase.

“The idea that COVID-19 or flu are just acute illnesses overlooks their larger long-term effects on human health,” Al-Aly said. “Before the pandemic, we tended to belittle most viral infections by regarding them as somewhat inconsequential: ‘You’ll get sick and get over it in a few days.’ But we’re discovering that is not everyone’s experience. Some people are ending up with serious long-term health issues. We need to wake up to this reality and stop trivializing viral infections and understand that they are major drivers of chronic diseases.”

Reference:

Yan Xie, Taeyoung Choi, Ziyad Al-Aly. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. The Lancet Infectious Diseases, 2023; DOI: 10.1016/S1473-3099(23)00684-9

Powered by WPeMatico

Psilocybin-assisted therapy may reduce depressive symptoms in adults with cancer and depression

Results from a phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psiloybe, may benefit individuals with cancer and major depression. Trial participants treated with psilocybin not only experienced a lessening of depressive symptoms but also spoke highly of the therapy when interviewed at the end of the trial. The findings are published by Wiley in two articles appearing online in CANCER, a peer-reviewed journal of the American Cancer Society.

By binding to a specific subtype of serotonin receptor in the brain, psilocybin can cause alterations to mood, cognition, and perception. Psilocybin is currently classified as a Schedule I drug-defined as having no accepted medical use and a high potential for abuse-and is not approved by the US Food and Drug Administration for clinical use. However, multiple randomized controlled trials have demonstrated the safety and potential efficacy of psilocybin-assisted therapy-which combines psilocybin with psychological support from trained therapists-to treat major depressive disorder. Additionally, ongoing research is looking into the use of psilocybin-assisted therapy for various other mental health conditions, such as anxiety, addiction, and post-traumatic stress disorder.

In this latest phase II open-label trial involving adults with cancer and major depression, 30 participants at Sunstone Therapies in Rockville, Maryland received a single 25 mg dose of synthesized psilocybin plus a 1:1 session with a therapist and group therapy support.

“This study was differentiated by its group approach. Cohorts of 3-4 patients were simultaneously treated with 25 mg of psilocybin in adjacent rooms open at the same time, in a 1:1 therapist:patient ratio. The cohorts had preparation for the therapy as well as integration sessions following the psilocybin session as a group,” explained lead author Manish Agrawal, MD, of Sunstone Therapies.

Participants enrolled had moderate to severe depression scores at baseline. After eight weeks of treatment, Dr. Agrawal and his colleagues observed that patients’ depression severity scores dropped by an average of 19.1 points, a magnitude that would indicate the majority no longer experienced depression. Furthermore, 80% of participants experienced a sustained response to treatment, and 50% showed full remission of depressive symptoms after one week, which was sustained for eight weeks. Treatment-related side effects such as nausea and headache were generally mild.

“As an oncologist for many years, I experienced the frustration of not being able to provide cancer care that treats the whole person, not just the tumor,” said Dr. Agrawal. “This was a small, open-label study and more research needs to be done, but the potential is significant and could have implications for helping millions of patients with cancer who are also struggling with the severe psychological impact of the disease.”

Dr. Agrawal is also the senior author of a second study led by Yvan Beaussant, MD, MSc, of Dana-Farber Cancer Institute that gathered input from patients in the trial during exit interviews. Participants described generally positive experiences. In terms of safety, they noted that being a part of the group calmed their fears and increased their sense of preparedness to engage in therapy. Regarding therapeutic efficacy, they felt that being connected to the group deepened and enriched their experience, ultimately contributing to their experience of self-transcendence and compassion for one another. Also, the use of both individual and group sessions was found to support the therapy in different ways. For example, the implementation of individual and group sessions allowed the therapy to remain an intimate introspective process while adding a sense of “togetherness” to it.

“As a hematologist and palliative care physician and researcher, it was profoundly moving and encouraging to witness the magnitude of participants’ improvement and the depth of their healing journey following their participation in the trial. Participants overwhelmingly expressed positive sentiments about their experience of psilocybin-assisted therapy while emphasizing the importance of the supportive, structured setting in which it took place,” said Dr. Beaussant. “Many described an ongoing transformative impact on their lives and well-being more than two months after having received psilocybin, feeling better equipped to cope with cancer and, for some, end of life.”

Before this intervention is implemented into clinical practice, additional studies should include larger numbers of patients, along with a control arm to compare its effects with other treatments or placebo.

Reference:

Manish Agrawal, William Richards, Yvan Beaussant, Sarah Shnayder, Rezvan Ameli, Kimberly Roddy, Norma Stevens, Brian Richards, Nick Schor, Betsy Jenkins, Mark Bates, Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder, Cancer, https://doi.org/10.1002/cncr.35010.

Powered by WPeMatico

Childhood caries tied to poor health and faster ageing in adulthood

Childhood caries is associated with poor health in adulthood and faster ageing suggests a new study published in the Journal of Public Health Dentistry.

Childhood caries is associated with poorer self-rated general health in adulthood, but it remains unclear whether that holds for physical health and aging. The aim of this study was to identify whether age-5 caries is associated with (a) biomarkers for poor physical health, and (b) the pace of aging (PoA) by age 45 years.

Participants are members of the Dunedin Multidisciplinary Health and Development Study birth cohort. At age 45, 94.1% (n = 938) of those still alive took part. Data on age-5 caries experience and age-45 health biomarkers were collected. The PoA captures age-related decline across the cardiovascular, metabolic, renal, immune, dental and pulmonary systems from age 26 to 45 years. We used (a) generalized estimating equations to examine associations between age-5 caries and poor physical health by age 45 years, and (b) ordinary least squares regression to examine whether age-5 caries was associated with the PoA. Analyses adjusted for sex, perinatal health, childhood SES and childhood IQ.

Results

High caries experience at age-5 was associated with higher risk for some metabolic abnormalities, including BMI ≥30, high waist circumference, and high serum leptin. Those with high caries experience at age-5 were aging at a faster rate by age 45 years than those who had been caries-free.

Oral health is essential for wellbeing. Poor oral health can be an early signal of a trajectory towards poor health in adulthood. Management for both conditions should be better-integrated; and integrated population-level prevention strategies should be foundational to any health system.

Reference:

Ruiz B, Broadbent JM, Thomson WM, Ramrakha S, Moffitt TE, Caspi A, et al. Childhood caries is associated with poor health and a faster pace of aging by midlife. J Public Health Dent. 2023; 83(4): 381–388. https://doi.org/10.1111/jphd.12591

Keywords:

Childhood, caries, associated, with, poor, health, adulthood, faster, ageing, Ruiz B, Broadbent JM, Thomson WM, Ramrakha S, Moffitt TE, Caspi, J Public Health Dent

Powered by WPeMatico

Study reveals association between very irregular sleep and higher risk of dementia

UK: A recent study published in Neurology, the medical journal of the American Academy of Neurology, has revealed that the regularity of a person’s sleep is an important factor when considering a person’s risk of dementia. 

The researchers showed that people who have very irregular sleep patterns may have a higher risk of dementia than those who have more regular sleep patterns. The study does not prove that sleep irregularity causes dementia. It only shows an association.

Sleep regularity is how consistent you are at going to sleep and waking up at the same time each day.

“Sleep health recommendations often focus on getting the recommended amount of sleep, which is seven to nine hours a night, but there is less emphasis on maintaining regular sleep schedules,” said study author Matthew Paul Pase, PhD of Monash University in Melbourne, Australia. “Our findings suggest the regularity of a person’s sleep is an important factor when considering a person’s risk of dementia.”

The study involved 88,094 people with an average age of 62 in the United Kingdom. They were followed for an average of seven years.

Participants wore a wrist device for seven days that measured their sleep cycle. Researchers then calculated the regularity of participants’ sleep. They determined the probability of being in the same sleep state, asleep or awake, at any two time points 24 hours apart, averaged over seven days. A person who sleeps and wakes at the exact same times each day would have a sleep regularity index of 100, while a person who sleeps and wakes at different times every day would have a score of zero.

Researchers then looked at medical data to identify which participants developed dementia and found 480 people developed the disease.

Researchers found links between sleep regularity scores and risk of dementia. Compared to those with an average sleep regularity index, the risk of dementia was highest for people who had the most irregular sleep.

People in the lowest fifth percentile had the most irregular sleep with an average score of 41. Those in the highest 95th percentile had the most regular sleep with an average score of 71. People between these two groups had an average sleep regularity score of 60.

After adjusting for age, sex and genetic risk of Alzheimer’s disease, researchers found that those with the most irregular sleep were 53% more likely to develop dementia than people in the middle group. For people with the most regular sleep, researchers found they did not have a lower risk of developing dementia than people in the middle group.

“Effective sleep health education combined with behavioral therapies can improve irregular sleep patterns,” Pase said. “Based on our findings, people with irregular sleep may only need to improve their sleep regularity to average levels, compared to very high levels, to prevent dementia. Future research is needed to confirm our findings.”

Pase said that although they adjusted for several factors that can affect the risk of dementia, they cannot rule out that another unknown factor may play a role in the association between sleep regularity and dementia.

Powered by WPeMatico

High Macular Fluid volume risk factor for progressive neovascular age-related macular degeneration

High Macular Fluid volume risk factor for progressive neovascular age-related macular degeneration suggests a new study published in the Canadian Journal of Ophthalmology.

A study was done to investigate the effect of macular fluid volumes (subretinal fluid [SRF], intraretinal fluid [IRF], and pigment epithelium detachment [PED]) after initial treatment on functional and structural outcomes in neovascular age-related macular degeneration in a real-world cohort from Fight Retinal Blindness!

Treatment-naive neovascular age-related macular degeneration patients from Fight Retinal Blindness! (Zürich, Switzerland) were included. Macular fluid on optical coherence tomography was automatically quantified using an approved artificial intelligence algorithm. Follow-up of macular fluid, number of anti-vascular endothelial growth factor treatments, effect of fluid volumes after initial treatment (high, top 25%; low, bottom 75%) on best-corrected visual acuity, and development of macular atrophy and fibrosis was investigated over 48 months.

Results

A total of 209 eyes (mean age, 78.3 years) were included. Patients with high IRF volumes after initial treatment differed by –2.6 (p = 0.021) and –7.4 letters (p = 0.007) at months 12 and 48, respectively. Eyes with high IRF received significantly more treatments (+1.6 [p < 0.001] and +5.3 [p = 0.002] at months 12 and 48, respectively). Patients with high SRF or PED had comparable best-corrected visual acuity outcomes but received significantly more treatments for SRF (+2.4 [p < 0.001] and +11.4 [p < 0.001] at months 12 and 48, respectively) and PED (+1.2 [p = 0.001] and +7.8 [p < 0.001] at months 12 and 48, respectively).

Patients with high macular fluid after initial treatment are at risk of losing vision that may not be compensable with higher treatment frequency for IRF. Higher treatment frequency for SRF and PED may result in comparable treatment outcomes. Quantification of macular fluid in all compartments is essential to detect eyes at risk of aggressive disease.

Reference:

Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration: results from Fight Retinal Blindness. Gregor S. Reiter, Virginia Mares Oliver Leingang, Hrvoje Bogunovic, Daniel Barthelmes, Ursula Schmidt-Erfurth

Open AccessPublished:November 18, 2023DOI:https://doi.org/10.1016/j.jcjo.2023.10.017

Keywords:

Long-term, effect, fluid, volumes, during, maintenance, phase, neovascular, age-related, macular, degeneration, results, Fight, Retinal, Blindness, Gregor S. Reiter, Virginia Mares Oliver Leingang, Hrvoje Bogunovic, Daniel Barthelmes, Ursula Schmidt-Erfurth, Canadian Journal of Ophthalmology

Powered by WPeMatico

Case of Treatment of woman with severe vasospastic angina with diltiazem- A report

Japan: Initiatin of diltiazem therapy led to pregnancy and the successful birth of a child in a woman diagnosed with severe vasospastic angina (VSA), a recent case study published in JACC: Case Reports has shown.

Vasospastic angina can sometimes result in acute myocardial infarction (MI) in pregnant women, potentially endangering mother and child lives. Hirohiko Aikawa, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan, and colleagues described a case of a young woman with suspected vasospastic angina who wished to become pregnant.

Vasospasm provocation testing revealed severe vasospasm and subsequent appropriate management led to successful delivery.

The case concerns a 29-year-old woman who presented with chest pain only at rest. The Holter electrocardiogram revealed ST-segment depression at the time of chest pain onset. A trial use of nitroglycerin sublingual tablets was effective. She was suggested to have vasospastic angina and wished to become pregnant. She had no medical history.

The possible differential diagnoses included coronary embolism, atherosclerotic coronary artery disease, and spontaneous coronary artery dissection.

The case was discussed by cardiologists and obstetricians who decided to perform invasive coronary catheterization and vasospasm provocation testing to determine a definitive diagnosis and perinatal cardiovascular risk and, to administer a calcium-channel blocker (CCB) if the test was positive.

Coronary angiography performed via her distal radial artery revealed no stenosis. Vasospasm provocation testing with acetylcholine administration into the left coronary artery resulted in sub occlusion in the left main trunk (LMT) with chest pain, ST-segment depression in the V4 to V6 leads, and hypotension. An intracoronary infusion of nicorandil and isosorbide mononitrate improved the LMT occlusion, eliminated electrocardiogram changes, and increased blood pressure (BP). She was confirmed to have severe VSA.

200 mg daily Diltiazem was initiated. She successfully conceived after a few weeks. Diltiazem’s effectiveness was recognised after the appearance of chest pain shortly after the temporary discontinuation of diltiazem because of hyperemesis gravidarum. Her pregnancy progressed without chest pain after the second trimester, and the fetus developed well.

A labour induction was planned at the 40th gestation week because spontaneous labour did not occur until full term. Epidural analgesia was used at delivery to prevent vasospasm induction caused by hyperventilation or pain stress.

She gave birth to a healthy girl without any anomaly. For postpartum atonic haemorrhage, oxytocin was used instead of methylergonovine. She had no chest pain or electrocardiogram abnormality in the peripartum period.

The patient continued to take diltiazem after delivery and has had no recurrence of angina attacks. The child was growing up without any disabilities. The amount of diltiazem ingested by the infant via breast milk is small and is unlikely to negatively affect breastfed infants.

“It is important to make a definitive VSA diagnosis for women who wish to be pregnant, determine its severity and provide suitable treatment,” the researchers wrote.

“Under conditions of adequate prior consultation with the patient, obstetricians, family, and cardiologists, invasive catheterization including provocation test should be performed, and CCB administration should be considered for VSA,” they concluded.

Reference:

Aikawa H, Murai K, Aoki-Kamiya C, Yoshimatsu J, Noguchi T. Diagnosis and Management of Vasospastic Angina in a Young Woman Wishing to Become Pregnant. JACC Case Rep. 2023 Dec 6;27:102051. doi: 10.1016/j.jaccas.2023.102051. PMID: 38094717; PMCID: PMC10715958.

Powered by WPeMatico

NEET PG: In Service Candidate alleges Arbitrary Seat Allotment at RVM Medical College, HC issues notice

Hyderabad: The Telangana High Court bench has recently issued notices in a plea challenging the arbitrary seat allotment to a postgraduate medical candidate in RVM Institute of Medical Sciences and Research Centre, Medak.

Issuing the notice, the HC bench comprising Chief Justice Alok Aradhe and Justice J. Anil Kumar has listed the matter for further hearing after two weeks.

The bench was considering a plea by an in-service PG medical candidate, who also belongs to the scheduled caste category. Approaching the HC bench, the petitioner alleged arbitrary seat allotment at the medical college.

It was submitted by the counsel for the petitioner that he belonged to the SC Category and he has secured 220 marks, whereas another candidate (Respondent No.3) was admitted to the Medak-based medical college while only obtaining 160 marks in the Postgraduate medical entrance examination, i.e. the National Eligibility-cum-Entrance Test Postgraduate (NEET-PG). The petitioner’s counsel also informed the court that the petitioner had submitted an option for the concerned medical institute as well.

The petitioner prayed to the court to issue an order or mandamus declaring the action of Kaloji Narayana Rao University of Health Sciences (KNRUHS) in not allotting a seat to the petitioner in PG SPM in terms of his web options, and allotting a PG SPM seat to another candidate who scored less as “illegal and arbitrary and discriminatory” violating the Article 14 and 21 of the Constitution of India.

Also Read: KNRUHS affiliated private medical, nursing colleges must pay GST on inspection, affiliation fee: HC

During the hearing of the case on 07.11.2023, the counsel for KNRUHS invited the Court’s attention to the notice dated 19.08.2023 issued by the Union Government which provides that the candidates who have participated in the first three rounds of counselling are not entitled to participate in the stray round of counselling.

It was submitted by the KNRUHS counsel that the petitioner has participated in up to the first three phases of counseling and had already been allotted a seat. Therefore, the petitioner was not entitled to participate in the stray round of counselling, which was held on 11.10.2023.

On 15.12.2023, when the matter came up for hearing before the HC bench, the counsel for KNRUHS invited the attention of the court to the stand taken by the university in paragraph 18 of the counter affidavit. 

As per the latest media report by Deccan Chronicle, the respondent informed the court that based on his marks, the petitioner had four options but he had applied for three. The petitioner’s counsel stated that one of the options was RVM Institute of Medical Sciences. While considering the matter, the HC bench said that without hearing the other candidate no orders could be passed and therefore, it directed to issue notice to the other candidate and adjourned the matter by two weeks.

“However, at this point of time, it is noticed that service on respondent No.3 has not been effected. Let service report be filed within two weeks. List thereafter,” the HC bench mentioned in the order.

To view the HC order, click on the link below:

https://medicaldialogues.in/pdf_upload/telangana-hc-kvm-institute-228151.pdf

Also Read: Telangana HC junks pleas seeking cancellation of MBBS seats allotted in stray round counselling

Powered by WPeMatico

Doctors cannot be blamed for consequences of pre-existing conditions: Consumer Court Relief to Orthopaedic Surgeon, Hospital

Chennai: The District Consumer Disputes Redressal Commission, Chennai (North), recently exonerated an Orthopaedic surgeon and a hospital from charges of medical negligence while opining that doctors cannot be held negligent for the consequences of treatment arising due to pre-existing conditions. 

Referring to relevant legal precedents, the Commission reiterated that medical practitioners would be liable only where their conduct fell below the standards of a reasonably competent practitioner in his field.

It further pointed out that in the realm of diagnosis and treatment, there is scope for difference of opinion and one professional doctor cannot be held negligent merely because his conclusion differs from that of other professional doctors. Doctors cannot be held negligent so long the doctor persons his/her duties with reasonable skill and competence.

With such opinions, the Commission exonerated a Chennai-based hospital and its Orthopaedic doctor (head of the Orthopaedics department) from charges of medical negligence while treating a patient diagnosed with comminuted intera articular supra condylar fracture of left distil femur.

After perusing the medical records, the consumer court opined that the doctor followed and adopted recognized medical procedure in respect of the surgery. Further, the Commission found that the increase in pain and the second surgery were because the complainant did not have normal shape or strength in his left leg due to pre-existing polio. Referring to this, the Commission opined that the doctor and the hospital cannot be blamed in this context and therefore they were not liable to pay the alleged medical expenses as demanded by the complainant.

The matter goes back to 2009 when the complainant sustained an injury on his left knee and was admitted to St. Isabel Hospital for treatment. He was diagnosed with comminuted intera articular supra condylar fracture of left distil femur with pain and swelling on his left knee. He was admitted as an in-patient and the head of the department of Orthopaedics in the hospital, the treating doctor, advised him to undergo surgery.

Accordingly, the doctor conducted surgery and the complainant was discharged on 12.06.2009. However, even after discharge, the pain continued and therefore the patient first consulted the treating doctor and later prof. Dr.P.V.A Mohandas at MIOT Hospitals Manappakkam, Chennai for a second opinion.

The complainant was shocked when the second doctor, after studying the X-ray, opined that the report showed a poor reduction of the fracture and therefore, he advised the complainant to have corrective surgery for realignment and knee-spanning fixation. Another doctor advised removal of entire implants assembling refixation after proper alignment of the supra condylar fracture and bone grafting. The Plan II, as advised by the doctor was that in case of deep infection, implant removal wound debridement and external fixation. Plan III was after the control of infection to plan for a definitive internal fixation and bone grafting.

Consequently, the patient was admitted to Balaji Hospitals Chennai to undergo corrective surgery on 22.06.2009 and the concerned doctor conducted the same. Under the corrective surgery after administering to the complainant spinal anaesthesia, the implant was removed and the madiel femur condyle was displaced and refixed. Then a vascular edge of shift of femur nibbled and fractured aligned and fixed with a contoured locking plate with screw. Post operative period was uneventful and the complainant was discharged from the hospital on 08.07.2009.

However, the complainant alleged that he had to pay substantial amount of money for the 1st surgery and also for the corrective surgery later which was necessitated because of gross negligence of the treating doctor at the first hospital. He demanded Rs 4,87,362.50 from the doctor and the hospital as compensation. 

On the other hand, the hospital submitted that it is a Charitable institution governed by nun sisters on a non-profitable basis. It also mentioned that the complainant was a known case of post-polio residual paralysis that had affected both his lower limbs even before the accident. Further, the hospital submitted that it did not decide to operate the very same day of admission but it was done later as a last resort attempt to extend the flexed knee.

It claimed that the nature and probable consequence of the surgery was explained to the complainant who was convinced that it was only an attempt to provide relief to the complainant from not only what he had sustained as a result of the alleged injury but also from what he had been suffering from prior to the fall.

As per the hospital, the patient was advised non-weight bearing knee brace and a review after 6 weeks and the requirement for a further review was also mentioned in the discharge summary which the complainant did not follow.

The treating doctor informed the consumer court that the complainant suffers from post polio residual paralysis of both legs with approximately 90 degree fixed flexion of the knees due to which he will not be able to straighten his legs at all.

He further submitted that as a reputed Orthopaedic surgeon, he was of the opinion that surgery should be done to correct the flexion deformity in the knee on the left leg to the maximum extent possible and due to pre existing polio the affected bone in his left leg does not have normal shape or strength. He also informed that the consequences of surgery were informed to the complainant prior to surgery and post operative pain is a common one and it takes time to for the fracture to heel.

Further, the doctor contended that he cannot be blamed for different opinions among professionals and further contended that the second treating doctor in no manner decry the earlier surgery it find fault with the same and the opinion of Dr Mohandass was based on X-ray showing poor reduction of fracture. The treating doctor opined that Dr. Mohandass’s opinion was misplaced since the complainant at no point in time had normal anatomy.

He further claimed that his attempt was to achieve flexibility in the complainant’s lower limb in the left leg so as to make the patient to stand up and the surgery done by him has been of the highest order and comparable with the services offered anywhere in the world.

After perusing the entire records and considering the arguments by both parties, the consumer court noted that the treating doctor conducted the surgery aiming at union of the fracture and to achieve strengthening of the lower limb in the left leg so that the patient  may try to stand since he was previously crawling with his knees.

Referring to the operation notes and discharge summary, the commission opined that the treating doctor

“…followed and adopted the recognized medical procedure in respect of the surgery undergone by the complainant and no fault and defectiveness in the surgery is established by the complainant or by the two other doctors who subsequently gave opinion by examining the complainant and therefore the question of negligence will not arise since the complainant fail to prove that the surgery has not be done in accordance with the normal and acceptable practice in the medical field…”

Noting the pre-existing polio of the complainant, the consumer court observed that the doctor cannot be held negligent for the consequences of the pre-existing condition of the patient and noted,

“…it is further found that the increase in pain and the 2nd surgery by Dr.L.Subramaniyan were due to the fact that the complainant does not have normal shape or strength in his left leg due to pre existing polio and for which the opposite parties cannot be blame by the complainant and hence the opposite parties or not liable to pay the alleged medical expenses of Rs.487362.50/- as claimed in the complaint.”

The Commission referred to Supreme Court order in the case of Kusum Sharma and Others versus Batra hospital and medical research centre and others and the landmark judgment in the case of Kusum Sharma and others Versus Batra hospital and medical research centre and others.

Referring to these orders, the Commission reiterated that a medical practioner would be liable only where is contact fell below that of the standards of a reasonably competent practioner in his field. It further opined that in the realm of diagnosis and treatment there is scope for difference of opinion and one professional doctor is not negligent merely because his conclusion differs from that of other professional doctors. It further reiterated that one professional doctor is not negligent merely because his conclusion differs from that of other professional doctors and negligence cannot be attributed to a doctor so long as he perform his duties with reasonable skill and competence.

Therefore, exonerating the doctor and the hospital, the Commission mentioned in the order,

“In the present complaint also the 2nd opposite party has done surgery with reasonable skill and competence and hence he cannot be held liable for medical negligence. The 2nd opposite party relied upon a decision reported in (2009) 9 Supreme Court Cases 709 and contended that without examining the expert as a witness in court no reliance can be placed on an opinion alone and hence contended without examining the two doctors who gave opinion it is not possible to come to a conclusion that the 2nd opposite party as committed medical negligence in performing surgery. The above said case is applicable to the present complaint and hence it is found after careful scrutiny of documents that the complainant failed to prove the alleged medical negligence on the part of opposite parties and hence there is no deficiency in service on the part of opposite parties.”

“Based on findings given to point.no.1 since there is no deficiency in service or medical negligence on the part of opposite parties hence the complainant is not entitled for sum of Rs.487362.50/- with interest as claimed in the complaint. Point no.2 is answered accordingly. In the result the complaint is dismissed. No cost,” it added.

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/chennai-dcdrc-228131.pdf

Also Read: Anaesthetist Alleges Wrongful Removal of Kidney, Consumer Court junks plea

Powered by WPeMatico

Study finds hypothyroidism closely associated with chronic kidney disease

A recent study published in Renal Failure uncovered a substantial association between hypothyroidism and chronic kidney disease (CKD), highlighting the prevalence of urine protein in patients with both conditions. The investigation wanted to unravel the mechanisms linking thyroid hormones and urine proteins, providing critical insights into the complex interplay between hypothyroidism and CKD.

The study conducted from November 2016 to August 2018, included 99 Japanese CKD patients with proteinuria. Major parameters assessed here were thyroid function (serum free T3, free T4, and thyroid-stimulating hormone), kidney function (estimated glomerular filtration rate), thyroid antibodies, and albumin. The research also looked into a comprehensive urine examination, examining levels of total T3, total T4, TSH, Alb, preAlb, thyroid-binding globulin, and overall protein.

The participants were of 60 years in average, with a slight male predominance (50.5%). Notably, around 70% of the patients displayed thyroid dysfunction, with 51.5% experiencing overt or subclinical hypothyroidism, irrespective of antibody status. Also, 21.2% of patients were diagnosed with nephrotic syndrome with a significant association between hypothyroidism and this renal complication. The study found higher urinary levels of thyroid hormones in patients with nephrotic syndrome, suggesting a more severe form of hypothyroidism.

These underscore that urinary loss of thyroid hormones may be a crucial factor influencing hypothyroidism independently of autoimmune factors. This established a link between hypothyroidism and nephrotic syndrome emphasizes the need for a comprehensive understanding of thyroid-kidney interactions in clinical management.

The outcomes deepens our understanding of the intricate relationship between hypothyroidism and chronic kidney disease and also opens avenues for targeted interventions. As we look further into the complexities of these interconnected health issues, this study marks a significant stride forward in advancing personalized treatment strategies for patients grappling with both hypothyroidism and chronic kidney disease.

Source:

Yuasa, R., Muramatsu, M., Saito, A., Osuka, H., Morita, T., Hamasaki, Y., & Sakai, K. (2023). Urinary excretion of thyroid hormone in CKD patients: a proof-of-concept of nephrogenic hypothyroidism. Renal Failure, 45(2). https://doi.org/10.1080/0886022x.2023.2293224

Powered by WPeMatico

Shweta Rai takes over as MD of Bayer Zydus Pharma

Thane: Bayer today announced that Shweta Rai will take over as Managing Director of Bayer Zydus Pharma Private Limited and Country Division Head (CDH) for Bayer’s Pharmaceuticals Business in South Asia effective, January 1, 2024. Manoj Saxena will move out of his present role to take on the role of CDH for Bayer’s Pharmaceuticals Division and Senior Bayer Representative, Bayer Group for the Australia & New Zealand (ANZ) cluster, with effect from the same date.

Shweta joined Bayer in 2019 and her last assignment was Business Unit Head. With a distinguished career spanning over 22 years, Shweta has a strong track record of leading high performance diverse teams across strategic business positions in the pharmaceuticals and medical device sectors. Her expertise extends across a myriad of therapy areas, including Cardiology, Diabetes, Women’s Health Care, Immunology, Virology, Anti-infectives, Vaccines, Neurology, Orthopedics and Pain Management. Prior to this, she worked with companies of repute like Johnson & Johnson, MSD Pharmaceuticals, IQVIA and Pfizer.

Shweta holds a bachelor’s degree in Zoology (Honors) from Miranda House Delhi University, a Postgraduate degree in Management Studies, Mumbai and completed a Strategic Management Program from the Indian Institute of Management (IIM), Kolkata.

Speaking about taking on the leadership role, Shweta said, “I am honored to take on this new role within the organization. I am committed to build on the strong foundation that has been laid by Manoj. I am confident we can continue to build on the successes we have witnessed in the region so far and take Bayer’s mission of ‘Health for All, Hunger for none’ forward. I am excited to work closely with internal and external stakeholders to continue delivering innovative healthcare solutions and exceptional value to our patients.”

Commenting on the appointment, Manoj said, “As I transition to a new role and country within our incredible organization, I am excited about the fresh challenges and opportunities that lie ahead. I am happy that Shweta is taking over this role for South Asia. She has been part of the India leadership team and demonstrated strong leadership over the years. I am equally confident that she will take Bayer’s Pharmaceuticals business to greater heights and help us leverage the emerging growth opportunities in this region. I am grateful for the unwavering support of our dedicated teams and look forward to contributing to our shared success in this exciting new chapter”.

Manoj joined Bayer in 2009 and has served in various leadership positions across multiple Asia Pacific countries. He is also currently the President-Elect at the Organization of Pharmaceutical Producers of India (OPPI).

Read also: Bayer, Salus Optima collaborate on AI-Enabled Healthy Aging Journey

Powered by WPeMatico